# ITVISMA

NDC: 71894-200
Generic name: onasemnogene abeparvovec-brve
Labeler / Manufacturer: Novartis Gene Therapies, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: INTRATHECAL
Marketing started: 20251124

FDA application: BLA125856

## Active ingredients

- ONASEMNOGENE ABEPARVOVEC: 40000000000000 [arb'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71894-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71894-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab2e1c6c-4f95-4243-9296-1734e0a30591